Reliant AI

Cohere announced the acquisition of Reliant AI, expanding its sovereign AI strategy and deepening its presence in the global healthcare and life sciences sectors. The deal brings Reliant AI's research team, proprietary biomedical datasets, and domain-opti

Acquisition advances our global sovereign AI strategy, integrates Reliant AI's domain-optimized technology into Cohere's offerings to accelerate innovation in global healthcare and life sciences and

This acquisition helps advance Cohere's global sovereign AI strategy in the highly regulated global healthcare and life sciences industry.

The engagement establishes a multi-phase framework to support AI enabled capital efficient development of Teverelix, a next generation GnRH antagonist, as a first in class market product for acute urinary retention (AURr) and high CV risk prostate ...

Reliant AI, a provider of gen AI-powered data analytics software, announced today it is launching out of stealth with $11.3 million in seed funding. This new funding round was co-led by Tola Capital and Inovia Capital, with participation from angel invest

Reliant AI has officially launched out of stealth and announced it has raised $15.4 million CAD ($11.3 million USD) in seed funding.

/PRNewswire/ -- Reliant AI, a provider of gen AI-powered data analytics software, announced today its launch out of stealth with $11.3 million in seed funding....